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Objective: To report our early experience with endovascular treatment of patients with ruptured abdominal aortic
aneurysms (RAAAs).
Methods: Between March 1998 and October 2004, 40 consecutive patients with an RAAA presented to our unit; 38
underwent assessment by computed tomography, whereas 2 died on arrival before any assessment and treatment was
possible. Twenty-three patients (61%) were suitable for stent grafting, and all proceeded to endovascular repair. Of these,
17 underwent operation with local anesthesia, 1 did so under general anesthesia, and a further 5 procedures were
commenced under local anesthesia and converted to general anesthesia. A total of 14 bifurcated and 10 aortouni-iliac
stent grafts were implanted; in 1 patient, the bifurcated graft was converted to an aortouni-iliac repair during surgery
because of technical difficulties.
Results: Stent-graft deployment in the intended location without a type I or III endoleak was technically successful in 22
of the 23 patients. There were no conversions to open surgery. The 30-day mortality was 39%. Six patients died
immediately or soon after the procedure because of severe hypovolemic shock, and three died within 30 days from cardiac
causes. After surgery, 13 complications were encountered in 10 patients (3 cardiac, 4 respiratory, 5 renal, and 1 implant
related). Two patients required reintervention—one for a type I endoleak and one for limb occlusion. There were 14
survivors. During a median follow-up of 410 days (range, 90-1650 days), 2 more patients died from myocardial
infarction, and 9 remain well; 3 patients were lost to follow-up. There were three secondary interventions (two for type
I endoleak and one for stent-graft thrombosis).
Conclusions: Endovascular treatment of RAAAs is feasible, and the early experience is promising. More experience and
evidence from randomized trials are needed to determine whether such an approach is superior to open surgery. (J Vasc
Surg 2005;42:615-23.)Rupture of an abdominal aortic aneurysm (AAA) is
associated with significant morbidity and mortality.1-3Al-
though elective open AAA repair has been associated with a
constant decline in operative mortality to nearly 5% during
the past decades, a similar decline has, unfortunately, not
occurred for ruptured AAAs (RAAAs), which have a mor-
tality range persisting in the 50% range.4,5 For hemody-
namically stable patients with contained rupture, this figure
is significantly less, in the range of 20% to 30%.6 However,
the overall risk of death from RAAA is even higher, ap-
proaching 80% to 90%, because less than half of the patients
reach the hospital alive.7 Although a recent meta-analysis of
50 years of RAAA repair did show a gradual reduction in
perioperative mortality, this gradual improvement in the
literature may reflect reporting bias and patient selection.8
Most of the recent literature on RAAAs has focused on
selecting patients who are likely to survive, and some au-
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doi:10.1016/j.jvs.2005.05.061thors have advocated abandoning treatment for patients
with risk factors that predict a poor outcome.3,9-12 Natu-
rally, selecting patients and operating only on those
deemed at good risk would improve the results from indi-
vidual series, but not the figures from population-based
studies, because rejected patients are condemned to al-
most-certain death.13 Endovascular techniques, increas-
ingly used for elective AAAs, could offer an attractive
option in ruptured cases because of the reduced physiolog-
ical stress.13-30 Whether the outcome of such patients
could be improved by endovascular surgery remains to be
seen. In this article, we present our initial experience with
the endovascular management of RAAAs over the last 6
years.
METHODS
A protocol for treating RAAAs by endovascular means
was initiated in our hospital in March 1998. Since then,
every patient admitted to this unit has been systematically
screened for endovascular eligibility. Assessment was by
means of contrast-enhanced spiral computed tomography
(CT) of the abdomen by using 5-mm slices. On arrival,
each patient was evaluated by the on-call vascular surgeon,
who remained with the patient throughout the preopera-
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cific hemodynamic inclusion/exclusion criteria for endo-
vascular repair; however, the surgeon in charge had the
option of sending the patient for immediate open repair in
cases of severe hemodynamic instability. The anatomic
criteria for offering emergent endovascular repair were
similar to those used in the elective setting, the most
important morphologic factor being the infrarenal neck.
The general guidelines for suitability were an infrarenal
neck length of 10 mm or more, a neck diameter of 32 mm
or less, neck angulation of 60° or less, and a common iliac
diameter of 22 mm or less; also, there could be no bilateral
common iliac aneurysms or long iliac occlusions.
A total of 40 consecutive patients presented to our unit
with an RAAA during the study period (March 1998 to
October 2004). Patients with acute or symptomatic but
intact aneurysms had been excluded. Two patients who had
been referred from remote hospitals with a suspected
RAAA died on arrival, before any assessment or treatment
was possible. Overall, 38 patients underwent assessment by
CT scanning. The eligibility rate for endovascular repair
was 61% (23/38). Of the 15 patients who were unsuitable
for stent grafting, 14 proceeded to open repair, and 1 died
before operation. Of the remaining 23 patients who were
anatomically suitable, all underwent endovascular repair,
and no patient was denied repair for logistic or clinical
reasons. These 23 patients were the focus of this study. In
all cases, relatives and, whenever possible, patients had
given informed consent for endovascular repair after discus-
sion of the severity of their clinical condition and dismal
prognosis.
Patients who were thought to be suitable for endovas-
cular repair were immediately transferred to a dedicated
vascular operating room with endovascular facilities. The
procedure was performed with a mobile C-arm image
intensifier with digital subtraction angiography facility. Ar-
terial access was obtained via bilateral surgical cutdowns of
the common femoral arteries by using skin crease groin
incisions. The procedure was usually performed under local
anesthesia with 1% lidocaine with adrenaline (1:200,000).
All patients were monitored noninvasively by the anesthe-
siologist. When needed, intravenous sedation was adminis-
tered to minimize patient movement and discomfort. In-
travenous fluid and blood resuscitation were minimized
before aneurysm exclusion to keep the systolic blood pres-
sure between 80 and 100 mm Hg. However, intravenous
nitroglycerin infusion to enforce this policy in hemody-
namically stable patients with a contained rupture was
not used.
Endovascular repair was then performed in standard
fashion by cannulation of both femoral arteries with suit-
ably sized sheaths, depending on the type of stent graft. No
aortic occlusion balloons were used before stent-graft de-
ployment in this series. Intraoperative angiography was
usually performed with manual injection of contrast via a
7F introducer sheath (Super ArrowFlex, 45 cm long; Arrow
International, Reading, Pa) inserted from the femoral ar-
tery contralateral to the side chosen for deployment of themain body of the stent graft. The contrast medium used
was iodixanol (Visipaque; AmershamHealth) or iopamidol
(Iopamiro 300; Bracco, Italy). Intraoperative angiography
determined the level of the lowest renal artery and, later in
the procedure, the origins of the internal iliac arteries. The
main body of the device was introduced over a stiff guide-
wire, such as the Amplatz Super Stiff (Boston Scientific,
Watertown, Mass) or the Lunderquist guidewire (TSMG-
35-260-5-LES2; William Cook Europe, Denmark) with
the help of a 5F guiding catheter, such as the Headhunter
(Boston Scientific, Meditech). The combination of a 5F
cobra-shaped selective angiographic catheter (Boston Sci-
entific, Meditech) and an angled Terumo guidewire (0.035
inches [180 cm]; Terumo Corporation, Tokyo, Japan) was
used to catheterize the short limb of the main body of the
bifurcated stent grafts in most cases. In all cases, stent grafts
were additionally dilated with a suitable balloon to ensure
adequate sealing. Postdilation was performed by using a
compliant aortic balloon catheter (Reliant; Medtronic,
World Medical Manufacturing Corp, Sunrise, Fla) for
proximal neck fixation or a nylon angioplasty balloon (C. R.
Bard Inc, Corrington) for iliac limb dilation.
Several types of stent-graft devices, including some
homemade stent grafts, were used during the study period.
In the early days, custom-made in-house devices were
available in tube, aortouni-iliac, and bifurcated design for
use in elective AAAs. Our experience with these has been
previously described in detail.31 In brief, these consisted of
a continuous self-expanding multiple Z-stent stainless-steel
structure covered with a pre-expanded polytetrafluoroeth-
ylene tube (commercial thin-wall 8- to 10-mm Impra and
Gore pre-expanded grafts). The grafts were compressed
into a 16F peel-away tube and advanced into position with
the help of a pusher through a long 16F sheath with a distal
radiopaque ring initially placed above the level of the renal
arteries. The graft was deployed by withdrawing the sheath.
During that period, an inventory of such homemade en-
dografts was initially kept in our hospital for use not only in
elective cases, but also in cases with symptomatic AAAs or
RAAAs and other acute arterial lesions, such as ruptured
aortas, pseudoaneurysms, or trauma cases. Two of the
patients included in this series received an aortouni-iliac
custom-made endograft with a 32-mm proximal diameter.
More recently, with the rapid developments made in the
field of stent-graft technology, we have moved away from
these homemade devices in favor of the new-generation
commercially available stent grafts, such as the Talent
(Medtronic World Medical, Sunrise), the Excluder (W.L.
Gore and Associates, Flagstaff, Ariz), the AneuRx (Medtronic
AVE, Santa Rosa, Calif), and the Endofit (Endomed Inc,
Phoenix, Ariz) systems.
The type of stent graft was chosen depending on the
surgeon’s preference, the anatomic characteristics of the
aneurysm, and, most importantly, the device availability.
Unlike in the earlier years, when an inventory of custom-
made devices was kept in our unit, more recently, a similar
stock of commercially available endografts for the explicit
purpose of repairing RAAAs has not been available as a
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suitable endografts was through the locally based company
representatives. As a result, whatever device was more
readily available was used. Although this policy could po-
tentially lead to inevitable logistic delays, frequent commu-
nication with the company representatives resulted in
timely endograft availability. In cases in which the diagnosis
of an RAAA was known or suspected through information
from the referring hospital or the ambulance service, we
alerted the company clinical specialists before patient ar-
rival, and the stent graft was available to us as the patient
was being brought to the operating room.
Twenty-three patients, 22 men and 1 woman, with a
median age of 73 years (range, 64-87 years), underwent
endovascular repair of an RAAA during the study period.
Table I summarizes the patient characteristics, pre-existing
comorbidities, and presenting features. All patients were
conscious on admittance and underwent contrast-en-
hanced CT of the abdomen to determine their suitability
for endovascular repair. The aneurysm characteristics are
presented in Table II. Most patients had a contained rup-
ture with a retroperitoneal hematoma, whereas four had
free intraperitoneal rupture. The median time from admis-
sion to arrival in the operating roomwas 50minutes (range,
35-140 minutes).
Seventeen patients underwent operation with local an-
esthetic infiltration in the groins, whereas one patient un-
derwent the procedure with general anesthesia. In another
five patients, the procedure started with a local anesthetic;
however, intubation and ventilation were subsequently re-
quired because two of them lost consciousness during the
Table I. Summary of patient demographics,
comorbidities, hemoglobin on admission, and lowest
recorded systolic blood pressure
Variable Data
Age, y, median (range) 73 (64-87)
Sex (male/female) 22/1
Comorbidities
Coronary artery disease 7 (30%)
Hypertension 21 (91%)
COPD 4 (17%)
Diabetes 4 (17%)
Chronic renal impairment 0 (0%)
CVA 2 (9%)
Presence of hostile abdomen 2
Obesity 8
Presentation
Pain (abdominal/back) 23
Patient conscious on arrival 23
Initial hemoglobin, g/dL, median (range) 8.8 (5.5-11.5)
Hypotension on admission (90 mm Hg) 9
Lowest recorded SBP (mm Hg)
90 5
70 3
50 1
COPD, Chronic obstructive pulmonary disease; CVA, cerebrovascular acci-
dent; SBP, systolic blood pressure.operation as a result of severe hypovolemic shock and threehemodynamically unstable patients developed severe dis-
comfort. Keeping them only under sedation with local
infiltration of the groins seemed impossible for continuing
the procedure.
The operative details are summarized in Table III. In
total, 14 bifurcated (11 Talent, 2 Excluder, and 1 AneuRx)
and 10 aortouni-iliac (2 Talent, 6 Endofit, and 2 custom-
made) stent grafts were implanted. The aortouni-iliac stent
grafts were supplemented by a femorofemoral crossover
bypass in all but one patient with a pre-existing chronic
occlusion of the contralateral iliac system. In 9 of 10 cases
of aortouni-iliac stent grafts, contralateral common iliac
artery flow was obliterated with an occluder. In the 10th
patient, a stent graft linking the contralateral external to
internal iliac artery was implanted to preserve pelvic flow:
the ipsilateral internal iliac artery had been sacrificed be-
cause of the presence of an aneurysm in the ipsilateral
common iliac artery.
In seven patients, additional endovascular maneuvers
were needed during the operation, with implantation of
Table II. Aneurysm anatomic features
Variable Data
Infrarenal neck diameter (mm) 26 (22-32)
Infrarenal neck length (mm) 20 (10-35)
AAA maximum diameter (mm) 78 (55-110)
Distal right CIA diameter (mm) 17 (9-38)
Distal left CIA diameter (mm) 19 (10-48)
Presence of iliac aneurysm, n (%) 6 (26%)
Free rupture, n (%) 4 (17%)
AAA, abdominal aortic aneurysm; CIA, common iliac artery. Values are
expressed as median (range) unless otherwise noted.
Table III. Operative details
Variable Data
Bifurcated vs aortouni-iliac approach 14/10
Femorofemoral crossover bypass 9
Type of stent graft
Talent 13
AneuRx 1
Excluder 2
Endofit 6
Homemade 2
Additional endovascular maneuvers 7 (30%)
Proximal stent 2
Distal stent 2
Proximal extension cuff 2
Distal extension cuff 2
Conversion of a bifurcated to aortouni-
iliac stent graft 1
Duration of the procedure (min) 100 (80-135)
Time from incision to excluding the
aneurysm (min) 40 (20-65)
Estimated blood loss (mL) 350 (100-1600)
Transfusion (units of blood) 3 (0-12)
Values are expressed as median (range), n, or n (%). A total of 24 stent grafts
were implanted in 23 patients.two proximal and two distal stents, four stent-graft exten-
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stent graft inside the previous one to secure stability and to
avoid migration. In this last patient, the original stent graft
was a bifurcated Talent with a 32-mm proximal diameter.
Because of technical error, the main body of the device was
placed in a lower position in the aneurysmal neck than
initially planned. This was related to technical problems
(poor image in an obese patient) and adverse anatomic
features (angulation). Because of concerns about the pos-
sibility of distal migration, we revised our original plan and,
instead of deploying the contralateral limb, advanced an
aortouni-iliac device (Endofit; 34-mm proximal diameter)
inside the previous stent graft with a more proximal fixa-
tion. This was ballooned into place by using a Reliant
balloon.
Primary technical success was defined on an intent-to-
treat basis according to the reporting standards for endo-
vascular aortic aneurysm repair of the Society for Vascular
Surgery/American Association for Vascular Surgery.32
This requires the successful introduction and deployment
of the device in the absence of surgical conversion or
mortality, type I or III endoleaks, or graft limb obstruction
and extends through the first 24-hour period. When un-
planned endovascular procedures were used, the term as-
sisted primary technical success was used. Surveillance and
follow-up consisted of contrast-enhanced spiral CT scans
(5-mm slices) and plain abdominal radiographs before dis-
charge, at 1, 3, 6, and 12 months, and annually thereafter.
Survival was determined by Kaplan-Meier survival curves
with SPSS (version 12.0) statistical software (SPSS Inc,
Chicago, Ill). CT scans provided us with information not
only on the aorta and stent grafts, but also on the progress
of the periaortic hematoma.
RESULTS
The operative results are summarized in Table IV.
Stent-graft deployment in the intended location without a
type I or III endoleak was technically successful in 22 of the
23 patients. There were no conversions to open graft repair.
The primary and assisted-primary technical success rates
were 43% and 74%, respectively. Eight patients died during
the hospital stay, and another one died within the first 30
postoperative days, thus giving an in-hospital mortality of
35% and a 30-day mortality of 39%. Six patients died either
immediately or within hours after completion of the endo-
vascular repair from multiple organ failure triggered by
severe hypovolemia. Five of these patients had developed
intractable intraoperative hypovolemic shock from which
they never recovered, despite resuscitation attempts. Of the
remaining three patients, one patient died on the 2nd
postoperative day from severe cardiopulmonary failure; one
patient died on the 6th postoperative day as a result of
pulmonary edema and acute renal failure (due to bilateral
renal artery occlusion by the stent graft) that necessitated
dialysis; and, finally, one patient died on the 29th postop-
erative day, 10 days after hospital discharge, as a result of
myocardial infarction. After surgery, eight patients were
admitted to the intensive care unit, and one had to betransferred there on the second postoperative day because
of severe cardiopulmonary failure. Of the six patients who
survived the intensive care unit stay and were later trans-
ferred back to the surgical ward, five were discharged with
no further complications.
Thirteen postoperative complications were encountered
in 10 patients, and in 3 patients these complications were
associated with a fatal outcome (Table IV). The major-
complication rate was 22%. Five patients had renal compli-
cations; four of these developed mild renal impairment
(20% increase in preoperative serum creatinine values).
However, as stated previously, the fifth patient experienced
acute renal failure after inadvertent occlusion of both renal
arteries by the stent graft. This was mostly related to the
poor image resolution during the procedure (obesity and
severe pain in an elderly patient with a history of coronary
artery disease resulting in movement artifact). Because of
severe comorbidities, this patient was thought to be un-
likely to survive conversion to open repair. Therefore, once
the end result was seen, it was decided to treat him expect-
antly with supportive measures, accepting that he would
need permanent dialysis. There was no correlation between
preoperative creatinine levels and the development of post-
operative renal impairment in this series. Additionally, four
patients developed respiratory failure, and two experienced
myocardial infarction. There were also two secondary rein-
terventions in the postoperative period. One patient devel-
oped a distal type I endoleak (from the ipsilateral limb) that
required implantation of a distal extension all the way down
the external iliac artery on the 10th postoperative day.
Finally, one patient developed bilateral lower limb ischemia
as a result of acute thrombosis of an Endofit aortouni-iliac
Table IV. Results of endovascular treatment
Variable Data
In-hospital mortality 8 (35%)
Thirty-day mortality 9 (39%)
Complications (total)* 13
Systemic 12
Cardiac 3 (all grade 3)
Respiratory 4 (2 grade 2; 2 grade 3)
Renal 5 (4 grade 1; 1 grade 3)
Implant related 1 (grade 2)
Technical success rate (successful
deployment in the intended
location without type I or
III endoleak) 22 (96%)
Primary technical success 43% (10/23)
Assisted-primary technical success 74% (17/23)
Secondary interventions within
30 d 2 (9%)
ICU admission 9 (39%)
Hospital stay (median days,
range) 10 (6-19)
ICU, Intensive Care Unit.
*Complications were classified according to the Society for Vascular Sur-
gery/American Association for Vascular Surgery reporting standards as mild
(grade 1), moderate (grade 2), and severe (grade 3) complications.32stent-graft 15 days after surgery. He required graft throm-
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an otherwise uneventful recovery.
Fourteen patients survived the operation and were dis-
charged home. Complete follow-up data were available for
11 of them (median, 410 days; range, 90-1650 days).
Three patients were lost to follow-up after attending the
3-month clinic appointment. All three were well at that
point, with no endoleaks on their CT scans. There were two
further late deaths during follow-up. Both patients, aged
83 years, had a history of coronary artery disease and died
from myocardial infarction 12 and 14 months after the
initial endovascular procedure. The cumulative survival
probability is presented graphically in Fig 1 (Kaplan-Meier
curve) and was 55% at 1 year and 48% at 3 years (Fig 1).
In most patients, there had been rapid regression of the
periaortic hematoma (Fig 2). There were also secondary
reinterventions in 3 of the 14 survivors. Two of them
developed secondary type I endoleak, one because of stent-
graft migration (1050 days after the initial procedure) and
one because of proximal neck dilation (560 days after
surgery). In both cases, the implant was a Talent device,
and there was no correlation with endograft sizing or the
preoperative anatomic features of the aneurysm. We pro-
ceeded with further endovascular maneuvers by implanting
additional proximal stent grafts to exclude the aneurysms.
The third patient presented with bilateral lower limb isch-
emia due to thrombosis of the aortouni-iliac stent graft 240
days after surgery. Stent-graft thrombectomy was at-
tempted initially but failed to restore satisfactory inflow
because of severe diffuse underlying atherosclerosis. This
was the most likely reason that the complication occurred
in the first place. Because there were no other endovascular
Fig 1. Cumulative survival probability of patients undergoing
endovascular repair of ruptured abdominal aortic aneurysms
(Kaplan-Meier survival curve).options, he was treated with an axillofemoral bypass graftand thrombectomy of the existing femorofemoral cross-
over graft.
DISCUSSION
Rupture of an AAA is a catastrophic and lethal event.
Given that many patients have multiple comorbidities and
that some may present in extremis, the idea of repairing the
rupture by endovascular means is appealing.13-30 Although
the long-term results of elective endovascular AAA repair
are still awaited, recent level I evidence from the EndoVas-
cular Aneurysm Repair 1 (EVAR 1) trial in the United
Kingdom shows that endovascular surgery can reduce the
operative risk by two thirds.33 Whether these benefits are
transferable to patients with an RAAA is unknown. Such
patients are debilitated, and avoiding laparotomy and aortic
cross-clamping by an endovascular approach is highly de-
sirable. Another reason that makes this approach unique is
that the sudden decompression of intra-abdominal pressure
associated with opening the abdomen is avoided, and the
usual accompanying decrease in blood pressure may not oc-
cur.17,18 In addition, the third-space losses due to the
laparotomy, the hypothermia, the blood loss, and the co-
agulopathy may all be minimized.13,17,18 Finally, it is im-
portant to keep in mind that in the elective setting, the aim
of treatment is to prevent aneurysm rupture, whereas in
ruptured cases, the aim is to prevent death: the long-term
results are not as important. RAAA patients, therefore, may
be ideal candidates for endovascular surgery provided that
they are morphologically suitable.
Although endovascular repair of an RAAA was first
reported by Yusuf et al14 in 1994, a review of the literature
through April 2005 identified a limited experience with
endovascular management of RAAAs.13 There have been
only a few studies, each encompassing no more than 25
patients, most of which have been published over the last 5
years (Table V).13-30 The perioperative mortality ranged
from 0% to 45%.When all series were combined, the overall
mortality was 22% (45/207). These results are much better
than those traditionally reported in the literature for open
repair. However, it should be stressed that these figures
may reflect increasing experience and patient selection.
Furthermore, they originate from pioneering centers from
around the world with significant experience in elective
endovascular AAA repair.13
In particular, there are three groups of patients in which
selection may influence the results.34 First, most studies
report on hemodynamically stable patients. In fact, only
27% of patients in the 14 series were hemodynamic unsta-
ble. Excluding patients with free intraperitoneal rupture,
instability, and hypotension—cases that may not be associ-
ated with survival at open repair—would certainly improve
the results.13 In the Zurich series, 58% of patients were
excluded from endovascular repair because of hemody-
namic contraindications.20 Although the 30-day mortality
of 39% in our study is what would be expected for open
repair in a mixed cohort including unstable patients, it
should be borne in mind that this includes a relatively
higher proportion of patients with hemodynamic instability
scan
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identified patients who would normally be turned down for
open repair because of serious comorbidities but who sub-
sequently undergo successful endovascular surgery and sur-
vive.13,34 In the series from Nottingham, 8 of 20 cases had
been refused open surgery.19 Also, all five patients in the
Philadelphia series25 and another three patients described
by Greenberg et al16 had been previously turned down for
open repair. They all underwent successful endovascular
aneurysm repair. Finally, some reports also include patients
with an acute, symptomatic AAA without documented
rupture. The Eindhoven, Rotterdam, and Groningen series
contain 24 emergent patients with symptomatic nonrup-
tured aneurysms; all underwent successful endovascular
aneurysm repair with no mortality.21,28,29 No such cases
were included in our series. Furthermore, it is important
to point out that during the study period, no selection
process was used other than that of the aneurysm’s
anatomic features and the stent-graft availability. This
all-comers policy is common practice in our country, par-
ticularly when patients are being admitted conscious in
Fig 2. Progress of a periaortic hematoma: preoperativeemergency rooms.There is concern that obtaining a preoperative CT scan
to facilitate endovascular repair may lead to unnecessary
delays in transferring patients to the operating room.13,35 A
UK study in the 1980s showed that the mean survival of
patients with RAAAs managed nonoperatively was 8 hours
after hospital admission.36 Recently, a Leicester study in-
vestigating patients admitted to the hospital with an RAAA
who did not undergo operation showed that most (87.5%)
patients died more than 2 hours after hospital admission.37
The median time from admission to death in this study was
10 hours 45minutes. These data indicate thatmost patients
with an RAAA who reach the hospital alive are sufficiently
stable to undergo CT and to be considered for endovascu-
lar repair. It is possible that implementation of an endovas-
cular RAAA program will result in some patients dying
before they undergo aneurysm repair.13 We had no deaths
in the CT scanner during our experience with endovascular
repair of RAAAs, whereas the Nottingham group reported
one such death.13 Furthermore, because of the logistic
difficulties, it is likely that offering an emergency RAAA
endovascular service will be possible only in major vascular
(A), 3 days after surgery (B), and 10 months later (C).centers. That would mean that patients may have to be
s with
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outlying units, thus increasing the delay to operation even
further. Whether this would increase the proportion of
patients who die during transfer remains to be seen. An
Edinburgh study, however, suggested that transfer of pa-
tients may not prejudice the overall population outcome of
RAAA.38 This is reassuring, because this unit accepts refer-
rals from all over the north and certain areas of central
Greece, and some of our patients have to travel in excess of
3 to 4 hours. Of course, others might speculate to quite the
contrary. As endovascular technology becomes more and
more commonplace, the ease of these procedures and the
standardized imaging protocols for preoperative assess-
ment might, indeed, make it the preferred option for
aneurysm repair: only patients unsuitable for endovascular
repair would be selected to go to tertiary centers for com-
plex open surgery.
The optimal endograft configuration, ie, bifurcated vs
aortouni-iliac, remains controversial in the setting of RAAA
repair. There are theoretical and real advantages and disad-
vantages to both. Because most of the elective endovascular
AAA procedures are performed by using commercially
available modular bifurcated systems, applying this exper-
tise to emergency cases is crucial in achieving rapid and safe
deployment of the graft and early hemorrhage control.34
The series from Zurich, Ulm, and Rotterdam, in which
commercially available modular bifurcated systems were
largely used, confirm this. A potential drawback is the time
Table V. Studies reporting on patients undergoing endov
Study No. patients Time period
Montefiore15,17,18 20 1994-1999 GA 
Nottingham13,14,19 20 1994-2000 GA (3
com
and
Cleveland, Rochester,
and Malmö16
3 1999 GA
Zurich20 21 1998-2001 GA in
(5 t
Eindhoven21 24† (17 RAAAs) 1999-2001 Usuall
Ulm22,23 24‡ 1995-2001 At leas
Malmö24 21 1997-2002 GA in
Philadelphia25 5 2001-2002 GA in
seda
Ghent26 9 1997-2002 GA in
Belfast27 14 1999-2002 Not sp
Groningen28 40† (25 RAAAs) 1998-2004 LA in 
LA
Rotterdam29 6† (4 RAAAs) 2001 Not sp
Heerlen30 1 2003 LA 
Thessaloniki 23 1998-2004 22 LA
GA, General anesthesia; LA, local anesthesia; AUI, aortouni-iliac; RAAA,
*Overall mortality was 22% (45/207); 30-day mortality is given whenever
†The Eindhoven, Rotterdam, and Groningen series also contain 24 patient
‡Also contains two traumatic and two anastomotic aneurysms.taken to cannulate the contralateral stump of the maindevice and deploy the contralateral iliac limb. Adjuncts
such as crossover catheter techniques (used by the Ulm
group) and occlusion balloons inflated within the stent
graft after deployment of themain body (used in the Zurich
series) may overcome this.13,20,22,23,34 The alternative
strategy is an aortouni-iliac approach.34 Although there are
advantages, such as the technical simplicity, speed of de-
ployment, and higher eligibility rate, this option also has all
the disadvantages of an extra-anatomic approach. In our
series, the decision to use one approach over another de-
pended mainly on endograft availability at the time of
presentation. Anatomic characteristics were also important.
For example, small or stenotic iliac arteries were better
suited to the lower-profile Excluder graft, whereas a Talent
graft would have beenmore appropriate for aneurysms with
a short proximal neck that required suprarenal fixation.
When an aortouni-iliac approach was chosen, an Endofit or
a Talent graft offered quick exclusion of the aneurysm and,
thus, better hemodynamic conditions.
The use of intraaortic occlusion balloons to provide tem-
porary hemostasis before definitive aneurysm exclusion is also
controversial. In this series, we did not use occlusion balloons
in any of our patients. We prefer, as do others, swift deploy-
ment of the graft with definitive hemorrhage control. Others
have used occlusion balloons selectively in hemodynamically
unstable patients in whom adequate systolic blood pressure
could not be maintained despite resuscitation measures. The
balloon catheters can be introduced via the brachial artery, as
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groups. However, insertion of the aortic balloon requires an
additional step in the procedure that may consume precious
time.As a result, theNottinghamandEindhovengroups both
favored expeditious graft deployment without the use of oc-
clusion balloons. Nevertheless, bearing in mind that all five of
our patients who developed hypovolemic shock during sur-
gery died, aortic occlusionballoon cathetersmay be of value in
unstable cases.
Finally, the use of local anesthesia may be the most
important factor in avoiding major hemodynamic distur-
bance and may account for the better chances of survival of
patients undergoing emergent endovascular repair. In 17 of
23 patients in our series and in 15 of 21 patients in the
Zurich series,20 endovascular repair was performed with
patients completely under local anesthesia, whereas another
5 patients in each center started under local anesthesia and
were converted to general anesthesia. However, not all
authors share the same enthusiasm about local anesthe-
sia.13,19,21 Their main criticism is that patients may become
restless and feel pain from the rupture and the endovascular
instrumentation of the aorta and iliac arteries.13,19 This
may result in movement artifact, which in turn may detri-
mentally influence the accuracy of the stent-graft deploy-
ment. Movement artifact was the reason for inadvertent
coverage of the renal arteries in one of our patients. Others
have encountered similar problems.13,19
The patients reported here represent our early experience
with endovascular repair of RAAAs. Undoubtedly, there will
be a learning curve, as seen in the elective cases. Despite this,
the results are encouraging.Naturally, there aremany issues to
be resolved and many problems to overcome, such as organi-
zation difficulties, availability of a wide range of stent grafts,
appropriate training of medical and paramedical personnel,
implementation of an out-of-hours emergency endovascular
on-call rota, and centralization of the vascular services. Nev-
ertheless, the preliminary results from several centers, includ-
ing ours, suggest that endovascular repair of RAAAs is feasible
and that it offers an opportunity for improved survival. In the
current era of clinical governance, well-designed, large-scale,
multicenter randomized trials will be needed to verify these
promising results.
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I have always wondered how many lives EVAR has saved.
There is no question that EVAR is less invasive and can be
performed with less discomfort compared with open surgery.
However, the recent update of the EVAR and the DREAM trials
has shown that the acute benefit of EVAR is quickly lost, and that
there is no survival advantage in themid-term. In short, EVARmay
provide greater comfort, but it may not have saved more lives
compared with open surgery.
On the other hand, EVAR for ruptured AAAs has the “poten-
tial” to actually save lives. We have extensive experience in this
field, and based on my personal “level 5” evidence, I continue to
believe that EVAR is the preferred treatment for most patients with
ruptured AAAs. Evidence is growing that EVAR may be better
than open surgery for patients with ruptured AAAs, and there is a
near consensus among experts that EVAR is the only way to go for
ruptured AAAs.
The article by Gerassimidis et al is further circumstantial
evidence that supports this belief. The fact that one can treat such
patients without laparotomy, which leads to release of tamponade
and worsening of hypotension, that one does not have to deal with
difficulties associated with the hematoma obscuring the anatomy,
which may lead to iatrogenic injury of the veins, ureter and the
bowels, that one can avoid reperfusion injury and visceral ischemia,
that one can avoid hypothermia, which often exacerbates the
coagulopathy, all makes sense and therefore it is very easy to jump
to this conclusion. However, one needs to be careful in interpret-
ing this result as well as those of others that report favorable
outcomes.
The most important issue requiring attention is that of patient
selection bias. Of the 38 patients who were treated during the
study period, 40% underwent open surgery. Although it is not clear
from the article, it is possible and likely that those who were
hemodynamically unstable were treated with open repair. Since the
authors did not have a stock of endografts in the hospital, they had
to scramble and call the company representatives to get an en-
dograft as soon as possible. This setting will certainly make it
difficult—and sometimes unethical—to performEVAR in a patient
with hemodynamic instability.
Equally important is the anatomic selection bias. Naturally,
those with pararenal AAAs or with more complex anatomy were
treated with open surgery. One needs to take into account these
issues before concluding whether 39% surgical mortality reported
in this series is good or not. As the authors point out, only
multicenter randomized trials can answer this question.
The anatomic eligibility was 61% in this series. However, for
our US readership, it is important to note that Gerassimidis et alUnited States, including the Talent (Medtronic, Minneapolis,
Minn) and the EndoFit (Endomed [LeMaitre Vasculare], Burling-
ton, Mass) endografts, which were used in more than 80% of cases.
It is known that ruptured AAAs have a shorter, wider neck, and
these endografts offer stents as large as 36 mm in diameter.1 Lack
of access to such endografts will certainly impact the eligibility rate
for patients treated in the United States. Availability of these
endografts is highly and urgently needed in the United States.
This series, as well as those published previously, have all been
reported by experienced physicians at centers of excellence. Each
operator had extensive experience in endografting in the elective
setting. One needs to be familiar with various devices and also be
proficient in the deployment of each before tackling these patients
under desperate conditions in which the margin for error is much
narrower. In addition to the authors’ excellent technique, which is
reflected by the 96% technical success, it is important not to
overlook the details that contributed to their respectable result.
This includes the use of permissive hypotension originally advo-
cated by Crawford,2 preferential use of local anesthetics, availabil-
ity of a dedicated endovascular operating room , ability to perform
computed tomography scans without delay, endovascular on-call
scheduling, and training of paramedic staff. Undoubtedly, the
devil is in the details.
In my practice, I routinely place a 5F sheath in the brachial
artery under local anesthesia and keep the guidewire placed in the
descending thoracic aorta before induction of general anesthesia or
initiation of the groin cut down.3 This allows one to quickly
upgrade the sheath and deploy an aortic occlusion balloon should
it become necessary. Although balloon occlusion has only been
used in 20% of our cases, for those cases that require it, it can mean
the difference between life and death. All five patients in this series
who experienced intra-operative hypotension were lost. These
patients might have benefited from the aortic occlusion balloon,
and I believe that this technique is worthwhile considering for both
open and EVAR for ruptured AAAs.
The authors are commended for saving (probably) lives.
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